Dakota Wealth Management Increases Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Dakota Wealth Management lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 38.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 4,634 shares of the biotechnology company’s stock after buying an additional 1,282 shares during the period. Dakota Wealth Management’s holdings in Axon Enterprise were worth $2,754,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in AXON. Quent Capital LLC increased its stake in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC increased its stake in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares in the last quarter. Versant Capital Management Inc raised its stake in shares of Axon Enterprise by 4,750.0% in the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after buying an additional 95 shares during the period. Brooklyn Investment Group purchased a new position in Axon Enterprise during the third quarter valued at approximately $41,000. Finally, Planning Capital Management Corp lifted its stake in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 55 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.3 %

Axon Enterprise stock opened at $607.60 on Thursday. The stock’s fifty day simple moving average is $617.26 and its 200-day simple moving average is $466.40. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $46.33 billion, a P/E ratio of 157.00, a P/E/G ratio of 6.07 and a beta of 1.04. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Finally, Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $504.92.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now owns 124,243 shares of the company’s stock, valued at approximately $77,586,026.21. The trade was a 0.83 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 in the last ninety days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.